Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :

or

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :

or

Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Khiron Ready to Commercialize & Distribute CBD Cannabis

Stockhouse Editorial
0 Comments| July 17, 2019


Medical cannabis Company Khiron Life Sciences Corp. (TSX: V.KHRNOTCQB: KHRNFForum) stated on Wednesday that it has obtained final approval to commercialize CBD production and has also received approval for an additional 17 cannabis strains from Colombian Agricultural Institute, bringing its total up to 22 strains. Sales are expected by Q3 2019.

For more, click here.

Khiron also announced this week that it will be a part of leading B2B beauty event, Cosmoprof North America, July 28th to July 30th at the Mandalay Bay Convention Center in Las Vegas, Nevada.


FULL DISCLOSURE: Khiron Life Sciences Corp. is a client of Stockhouse Publishing.



Interested in these industries and sectors?

Receive investor kits and email updates from Stockhouse and directly from these companies.

Healthcare
Technology
Metals & Mining
Technology
Industrials

Interested in these industries and sectors?

You are already a member! Please enter your password to sign in.

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to access this feature.


×

StockTalk
Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.